Literature DB >> 19070018

The prevalence of hepatitis B, hepatitis C and HIV infections in non-IV drug opioid poisoned patients in Tehran-Iran.

H Talaie1, S H Shadnia, A Okazi, A Pajouhmand, H Hasanian, H Arianpoor.   

Abstract

The present study intends to look into the prevalence of these infections in the non-IVdrug abusing addicts whom were treated at our center. A pilot study was conducted on 20 patients who were admitted in poisoning center of Loghman-Hakim Hospital in Tehran due to non-IV drug overdose. One positive HIV antibody and one positive HBS antigen cases were found in this group. The pilot study was later expanded to a descriptive cross-sectional study on 214 patients. In this study 196 patients (91.6%) were male and 18 (8.4%) were female. The average age of subjects was 37.9, having the highest frequency between 20 to 30-years-old. The study showed that 14.48% (F = 31) had positive HCV antibody and 1.86% (F = 4) had positive HBS antigen and 1.4% (F = 3) had positive HIV antibody in their blood serum. One hundred and forty three patients (66.8%), were poisoned through oral opium consumption, 24 patients (11.2%) through inhalation and 18 (8.4%) both oral and inhalation. The remain; were IV-abuser or the manner of poisoning was unknown. This study signifies the need for heightened attention and preventive measures against the infection of the health care professionals by hepatitis C (HCV) virus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 19070018     DOI: 10.3923/pjbs.2007.220.224

Source DB:  PubMed          Journal:  Pak J Biol Sci        ISSN: 1028-8880


  6 in total

Review 1.  HIV infection and risk of overdose: a systematic review and meta-analysis.

Authors:  Traci C Green; Samuel K McGowan; Michael A Yokell; Enrique R Pouget; Josiah D Rich
Journal:  AIDS       Date:  2012-02-20       Impact factor: 4.177

Review 2.  Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: an analysis using hepatitis C virus as a proxy biomarker.

Authors:  Yousra A Mohamoud; F DeWolfe Miller; Laith J Abu-Raddad
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 3.  High hepatitis C virus prevalence among drug users in Iran: systematic review and meta-analysis of epidemiological evidence (2001-2012).

Authors:  Mohsen Malekinejad; Soodabeh Navadeh; Ali Lotfizadeh; Afarin Rahimi-Movaghar; Masoumeh Amin-Esmaeili; Alireza Noroozi
Journal:  Int J Infect Dis       Date:  2015-10-13       Impact factor: 3.623

Review 4.  Prevalence of hepatitis B virus infection among Iranian high risk groups: a systematic review and meta-analysis.

Authors:  Amir Almasi-Hashiani; Erfan Ayubi; Kamyar Mansori; Mostafa Salehi-Vaziri; Yousef Moradi; Behzad Gholamaliei; Salman Khazaei
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2018

5.  Prevalence of Hepatitis C Virus Infection in General Population of Mashhad, Northeastern Iran.

Authors:  Sanaz Ahmadi Ghezeldasht; Mohammad Reza Hedayati-Moghaddam; Khosro Shamsian; Farhad Fathimoghadam; Hamid Reza Bidkhori; Seyed Abdolrahim Rezaee
Journal:  Iran J Public Health       Date:  2017-03       Impact factor: 1.429

Review 6.  Hepatitis B virus infection among people who use drugs in Iran: a systematic review, meta-analysis, and trend analysis.

Authors:  Yasna Rostam-Abadi; Hossein Rafiemanesh; Jaleh Gholami; Behrang Shadloo; Masoumeh Amin-Esmaeili; Afarin Rahimi-Movaghar
Journal:  Harm Reduct J       Date:  2020-10-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.